Norpramin (desipramine hydrochloride) - Dear Healthcare Professional Letter

Links shared publicly online about this topic.

  • 1,558
    total visits

Norpramin (desipramine hydrochloride) - Dear Healthcare Professional Letter

fda.gov

Risk of sudden death and cardiac dysrhythmias in patients being treated with Norpramin.

View full resource at fda.gov

Tags: Heart, Arrhythmia, Antidepressant, Healthcare, Norpramin

  • Share

Most Recently Shared on December 3, 2009 at 4:38 am By:

tdanton Trish D'Antonio

"Norpramin (desipramine hydrochloride) - Dear Healthcare Professional Letter" ( http://bit.ly/6V7Grg )

2 years ago...

Symposier - New Warnings on Norpramin (February 2010)

symposier.com — “Uploaded and Shared in Youtube by: LawsuitGuru Sanofi-Aventis is notifying healthcare professionals about updated safety information for the antidepressant Norpramin (desipramine hydrochloride). The section on overdosage now notes that overdoses of this drug have resulted in a higher death rate than overdoses of other tricyclic antidepressants. Also, a new warning in the labeling now says to use extreme caution when giving this drug to patients with a family history of sudden death, cardiac dysrView full resource at symposier.com

  • View Related
  • Share

Most Recently Shared on May 21, 2010 at 11:30 am By:

s_canning Sally Canning Doctor, Psychologist, and PhD

RT @SympoPsychiatry New Warnings on Norpramin(desipramine hydrochloride, antidepressant) - February-2010 http://bit.ly/czOJrl

2 years ago...

Advertisement